DARA BioSciences Secures Additional Intellectual Property Relating to Spicamycin (Including KRN5500)

RALEIGH, N.C., Nov. 4, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) today announces that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (PTO) for U.S. Patent Application No.... [read full story]                    

powered by
Add Comment
There are also 4 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies
COMMENTS 

default
(anonymous) - Nov 4, 2009
Hi, The market is currently enjoying a good rally which has seen most stocks gain from competitive advantage and it would be advisable for all stock market enthusiasts to seize this opportunity and plan their investments in a safer yet conducive stock market. With NIFTY hovering around 4800-4900 +, it is expected to take hold of this currently rally and be realistically be closest to 5000 more so than before in what should be its new 52 week high. Lot many untouched stocks are still there which are ready to blast any moment. Regards SHARETIPSINFO TEAM
0  |  Reply